Mutations in human MTO1 have been implicated in hypertrophic cardiomyopathy and lactic acidosis [39]; introduction of the corresponding mutations into yeast MTO1 result in a defective enzyme, which only partially rescued a Δmto1 yeast mutant [39]. Here, MTO1 is linked to hypertrophic cardiomyopathy.